Showing results (341-350 of 547) with videos related to

Sort By:
Pageof 55
The International Journal of Eating Disorders|March 9, 2010
Sodium oxybate in the treatment of binge eating disorder: an open-label, prospective studySusan L McElroy, Anna I Guerdjikova, Erin L Winstanley, et al.
Bipolar Disorders|May 3, 2001
A pilot study of rapid lithium administration in the treatment of acute maniaP E Keck, S M Strakowski, J M Hawkins, et al.
International Clinical Psychopharmacology|September 24, 2010
A randomized, placebo-controlled study of adjunctive ramelteon in ambulatory bipolar I disorder with manic symptoms and sleep disturbanceSusan L McElroy, Erin L Winstanley, Brian Martens, et al.
The Journal of Clinical Psychiatry|March 25, 2000
Twelve-month outcome in bipolar patients with and without personality disordersE Dunayevich, K W Sax, P E Keck, et al.
The Journal of Clinical Psychiatry|April 6, 2010
Randomized, double-blind, placebo-controlled study of divalproex extended release loading monotherapy in ambulatory bipolar spectrum disorder patients with moderate-to-severe hypomania or mild maniaSusan L McElroy, Brian E Martens, Ryan S Creech, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 22, 2001
Neuroendocrine and behavioral effects of repetitive transcranial magnetic stimulation in a psychopathological animal model are suggestive of antidepressant-like effectsM E Keck, T Welt, A Post, et al.
International Clinical Psychopharmacology|October 24, 2014
Adjunctive lisdexamfetamine in bipolar depression: a preliminary randomized, placebo-controlled trialSusan L McElroy, Brian E Martens, Nicole Mori, et al.
Human Psychopharmacology|September 22, 2016
Lisdexamfetamine dimesylate in binge eating disorder: a placebo controlled trialAnna I Guerdjikova, Nicole Mori, Thomas J Blom, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 18, 2003
Reduction of hypothalamic vasopressinergic hyperdrive contributes to clinically relevant behavioral and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat modelMartin E Keck, Tobias Welt, Marianne B Müller, et al.
Psychiatry Research|August 30, 1996
Personality disorders in first- and multiple-episode maniaE Dunayevich, S M Strakowski, K W Sax, et al.
Pageof 55